The outcome of the study was negative, in that neither glargine nor omacor reduced the rate of CV outcomes. There were, however, some positive messages (Glycosmedia)
Diabetes News Service
The outcome of the study was negative, in that neither glargine nor omacor reduced the rate of CV outcomes. There were, however, some positive messages (Glycosmedia)
For iPhone and iPad | For Android devices
For information about sponsorship and advertising please contact our editor-in-chief Jim Young jim@glycosmedia.com
Website by Wired up Wales